Logo image

Dendritic Cell Therapy (DCT) - Cancer Treatment with Dendritic Cell-based Vaccine | Centre of Advanced Medicine, Frankfurt, Germany

Dendritic Cell Therapy (DCT) - Cancer Treatment with Dendritic Cell-based Vaccine | Centre of Advanced Medicine, Frankfurt, Germany
9.30

Frankfurt am Main, Germany

5
User ScoreRatingMedia Files
94%9.3/105

Overview

Age group

Kids, Adults

Type of care

Outpatient

Method

Non-surgical

About the offer

Dendritic cell-based cancer vaccines are a type of immunotherapy in which the patient's dendritic cells are used to make the immune system attack cancer cells. Dendritic cells are significant to the immune response because they show foreign substances to T cells, white blood cells crucial to the immune reaction. In making a vaccine, dendritic cells from the patient's blood or bone marrow are taken and put in a lab where they are exposed to cancer antigens. The dendritic cells are then given back to the patient, where they can help the immune system fight cancer cells. In the constantly evolving field of medical treatments, new and innovative therapies are emerging that offer hope for breakthroughs in treating various diseases. One such approach is Dendritic Cell Therapy (DCT), which is a form of immunotherapy that uses the body's own immune system to fight diseases. Each patient's dendritic cells are used to make a dendritic cell-based cancer vaccine, so each vaccine is unique. Dendritic cell-based cancer vaccines may target and kill cancer cells. They use dendritic cells to make the immune system attack cancer cells. Since vaccines are made from the patient's cells, they may have fewer side effects than other cancer treatments. Cancer vaccines made from dendritic cells might cause the immune system to respond to cancer cells in a way that lasts for a long time. It could make it less likely that cancer will come back. Dendritic Cell Therapy (DCT), also known as vaccine therapy, is an advanced immunotherapy that utilizes dendritic cells. These cells are the sentinels of the immune system and can trigger an immune response against specific targets, such as cancer cells or pathogens. Dendritic cells have a key role in identifying foreign invaders, and they activate other immune cells to recognize and eliminate these cancer cells or pathogens. How does Dendritic Cell Therapy work?Dendritic Cell Therapy (DCT) is a process that involves isolating dendritic cells from either a patient's blood or bone marrow. These cells are then exposed to antigens derived from the target disease, such as cancer-specific antigens or microbial components. This exposure activates and primes the dendritic cells. Once activated, the dendritic cells move to the lymphoid organs where they interact with T cells, which are essential in adaptive immunity. The dendritic cells activate the T cells, which results in a targeted immune response against cells that express the antigen, such as cancer cells or infected cells. This response ultimately leads to the death of the cells or pathogens. Main indicationsCancer immunotherapy: DCT is being investigated as a potential treatment for various advanced metastatic cancers, including melanoma, prostate, pancreatic, lung, colon cancer, and glioblastoma;Infectious diseases: DCT shows promise for treating viral (HIV, Hep B/C) & bacterial infections;Autoimmune diseases: Modulating immune responses could provide new avenues for treating autoimmune conditions such as rheumatoid arthritis and multiple sclerosis.

What’s included

Medical service

Examination
  • clinical history-taking
  • medical records review
  • physical examination
  • consultation with an oncologist
  • consultation with an immunologist
Laboratory tests
  • complete blood count (CBC)
  • biochemical analysis of blood (kidney and liver function tests, electrolytes)
  • inflammation blood tests
Diagnosis
  • ultrasound imaging
  • CT/MRI scan
  • fine needle aspiration biopsy of the tumor
  • histopathological specimen examination
  • immunohistochemistry test (IHC)
Treatment
  • pre-procedure patient preparation
  • autologous dendritic cell harvesting
  • dendritic cells incubation and activation
  • infusion of mature dendritic cells
  • post-procedure care
  • symptomatic treatment
Other
  • cost of the drug production
  • cost of essential medicines
  • cost of essential materials
  • nursing service
  • discharge medical records
  • further recommendations

Extra add-ons

Local transportation
Airport transfer
Personal coordinator
HealthDocs translate
Language Assistance

AiroCare

AiroMedical support
Payment protection
Patient advocacy
Price match

Meet the provider

Dr. med. Gerhard Siebenhuner

holistic and regenerative medicine, biological cancer therapy and complementary oncology, anti-aging

9.30
Excellent

Why to choose us?

Targeted immune response
Dendritic cells are remarkable in their ability to selectively target cells that express the specific antigen of interest. This targeted approach minimizes the risk of damage to healthy tissues, making dendritic cells a promising avenue for medical research and treatment.
Long-lasting immunity
By inducing memory T cell responses, DCT provides a powerful means of protecting against disease recurrence. With this innovative approach, patients can achieve lasting immunity and enjoy long-term peace of mind. Choose DCT for a more effective and comprehensive solution to disease prevention.
Personalized treatment
Since dendritic cells are sourced from the patient's own body, they hold immense potential for reducing the risk of adverse reactions or rejection. By leveraging this natural advantage, we can ensure a safe and effective solution for patients seeking treatment.
Synergistic potential
By incorporating DCT with chemotherapy, radiation, or checkpoint inhibitors, we can significantly enhance the effectiveness of cancer treatment. DCT acts as a complementary therapy, reinforcing the benefits of these treatments and improving overall response rates. If you or a loved one is battling cancer, consider discussing the potential benefits of DCT with your healthcare provider as part of a comprehensive treatment plan. Together, we can work towards achieving the best possible outcome.

Customize this offer

If you're not seeing exactly what you need here, send your custom request. You can discuss the content, specifics, price & timeline to create a personalized plan.

Location

Vilbeler Landstraße, 45B, 60388 Frankfurt am Main Germany

FAQ

What is the cost?

The total price for Dendritic Cell Therapy (DCT) - Cancer Treatment with Dendritic Cell-based Vaccine | Centre of Advanced Medicine, Frankfurt, Germany is €47,891. However, it can vary from the specifics of each case. Get in touch to get an individual estimate.

What is the rating of the offer?

Dendritic Cell Therapy (DCT) - Cancer Treatment with Dendritic Cell-based Vaccine | Centre of Advanced Medicine, Frankfurt, Germany is rated as 9.30 by AiroMedical.

Who is offering a deal?

How long does the offer take?

The offer is designed for 14 days.

What are the age restrictions?

The offer is eligible for both adults and kids.

Can I customize the content of the offer?

Yes, the components of the deal can be changed. Get in touch with a vendor to create a personalized proposal.

Does the offer include extra services?

Individual cost estimate. Non-binding 100% free assessment.

€47,891

Similar deals